293 related articles for article (PubMed ID: 12667686)
21. Functional maturation of the human antibody response to rotavirus.
Kallewaard NL; McKinney BA; Gu Y; Chen A; Prasad BV; Crowe JE
J Immunol; 2008 Mar; 180(6):3980-9. PubMed ID: 18322207
[TBL] [Abstract][Full Text] [Related]
22. A time-resolved immunoassay to measure serum antibodies to the rotavirus VP6 capsid protein.
Kavanagh O; Zeng XL; Ramani S; Mukhopadhya I; Crawford SE; Kang G; Estes MK
J Virol Methods; 2013 Apr; 189(1):228-31. PubMed ID: 23183143
[TBL] [Abstract][Full Text] [Related]
23. Neutralisation and binding of VHS virus by monovalent antibody fragments.
Cupit PM; Lorenzen N; Strachan G; Kemp GJ; Secombes CJ; Cunningham C
Virus Res; 2001 Dec; 81(1-2):47-56. PubMed ID: 11682124
[TBL] [Abstract][Full Text] [Related]
24. Rotavirus-neutralizing antibodies inhibit virus binding to integrins alpha 2 beta 1 and alpha 4 beta 1.
Fleming FE; Graham KL; Taniguchi K; Takada Y; Coulson BS
Arch Virol; 2007; 152(6):1087-101. PubMed ID: 17318737
[TBL] [Abstract][Full Text] [Related]
25. Human monoclonal Fab fragments from a combinatorial library prepared from an individual with a low serum titer to a virus.
Bender E; Pilkington GR; Burton DR
Hum Antibodies Hybridomas; 1994; 5(1-2):3-8. PubMed ID: 7858180
[TBL] [Abstract][Full Text] [Related]
26. Rapid generation of rotavirus-specific human monoclonal antibodies from small-intestinal mucosa.
Di Niro R; Mesin L; Raki M; Zheng NY; Lund-Johansen F; Lundin KE; Charpilienne A; Poncet D; Wilson PC; Sollid LM
J Immunol; 2010 Nov; 185(9):5377-83. PubMed ID: 20935207
[TBL] [Abstract][Full Text] [Related]
27. Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore.
Aiyegbo MS; Sapparapu G; Spiller BW; Eli IM; Williams DR; Kim R; Lee DE; Liu T; Li S; Woods VL; Nannemann DP; Meiler J; Stewart PL; Crowe JE
PLoS One; 2013; 8(5):e61101. PubMed ID: 23671563
[TBL] [Abstract][Full Text] [Related]
28. Both VH and VL chains of polyreactive IgM antibody are required for polyreactivity: expression of Fab in Escherichia coli.
Cheung SC; Takeda S; Notkins AL
Clin Exp Immunol; 1995 Aug; 101(2):383-6. PubMed ID: 7648724
[TBL] [Abstract][Full Text] [Related]
29. Generation of porcine monoclonal antibodies based on single cell technologies.
Li K; Bai J; Du L; Wang X; Ke C; Yan W; Li C; Ren L; Han H; Zhao Y
Vet Immunol Immunopathol; 2019 Sep; 215():109913. PubMed ID: 31420069
[TBL] [Abstract][Full Text] [Related]
30. A simple way to increase recovery of the expressed
Guselnikov SV; Belovezhets TN; Kulemzin SV; Gorchakov AA; Taranin AV
Biotechniques; 2019 Oct; 67(4):184-187. PubMed ID: 31411041
[TBL] [Abstract][Full Text] [Related]
31. Isolation of human monoclonal antibodies that neutralize human rotavirus.
Higo-Moriguchi K; Akahori Y; Iba Y; Kurosawa Y; Taniguchi K
J Virol; 2004 Apr; 78(7):3325-32. PubMed ID: 15016854
[TBL] [Abstract][Full Text] [Related]
32. VP4- and VP7-specific antibodies mediate heterotypic immunity to rotavirus in humans.
Nair N; Feng N; Blum LK; Sanyal M; Ding S; Jiang B; Sen A; Morton JM; He XS; Robinson WH; Greenberg HB
Sci Transl Med; 2017 Jun; 9(395):. PubMed ID: 28637924
[TBL] [Abstract][Full Text] [Related]
33. Two neutralizing human anti-RSV antibodies: cloning, expression, and characterization.
Heard C; Brams P; Walsh E; Huynh T; Chamat S; Reff M; Owyang A; Shestowsky W; Newman R
Mol Med; 1999 Jan; 5(1):35-45. PubMed ID: 10072446
[TBL] [Abstract][Full Text] [Related]
34. [Construction and preliminary panning of Fab phage display antibody library against respiratory syncytial virus].
Wang ZH; Zhang GC; Li AM
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):681-5. PubMed ID: 19102829
[TBL] [Abstract][Full Text] [Related]
35. Neutralizing murine monoclonal antibodies to human IL-5 isolated from hybridomas and a filamentous phage Fab display library.
Ames RS; Tornetta MA; McMillan LJ; Kaiser KF; Holmes SD; Appelbaum E; Cusimano DM; Theisen TW; Gross MS; Jones CS
J Immunol; 1995 Jun; 154(12):6355-64. PubMed ID: 7759873
[TBL] [Abstract][Full Text] [Related]
36. Rotavirus vaccination and infection induce VP6-specific IgA responses.
Lappalainen S; Blazevic V; Malm M; Vesikari T
J Med Virol; 2017 Feb; 89(2):239-245. PubMed ID: 27431308
[TBL] [Abstract][Full Text] [Related]
37. Production of recombinant Ig molecules from antigen-selected single B cells and restricted usage of Ig-gene segments by anti-D antibodies.
Dohmen SE; Mulder A; Verhagen OJ; Eijsink C; Franke-van Dijk ME; van der Schoot CE
J Immunol Methods; 2005 Mar; 298(1-2):9-20. PubMed ID: 15847793
[TBL] [Abstract][Full Text] [Related]
38. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning.
Tiller T; Meffre E; Yurasov S; Tsuiji M; Nussenzweig MC; Wardemann H
J Immunol Methods; 2008 Jan; 329(1-2):112-24. PubMed ID: 17996249
[TBL] [Abstract][Full Text] [Related]
39. Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo.
Lappalainen S; Pastor AR; Tamminen K; López-Guerrero V; Esquivel-Guadarrama F; Palomares LA; Vesikari T; Blazevic V
Hum Vaccin Immunother; 2014; 10(7):2039-47. PubMed ID: 25424814
[TBL] [Abstract][Full Text] [Related]
40. A genetic approach to the generation of antibodies with enhanced catalytic activities.
Lesley SA; Patten PA; Schultz PG
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1160-5. PubMed ID: 8094556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
